Testing the Gravitostat in Humans: the Impact of a Weighted Vest in Patients Post Bariatric Surgery on Fat-free Mass Retention and Weight Loss
Study Details
Study Description
Brief Summary
The mechanisms regulating fat mass homeostasis are incompletely understood although recent animal and human trials would suggest that there is a leptin independent regulatory pathway which may play a role in weight control and maintenance. Although evidence would suggest that external loading in patients with obesity may promote body weight loss, this has not been explored in patients following bariatric surgery.
The aim of this study is to investigate the mechanisms regulating weight loss and the potential role of the 'gravitostat' in fat free mass retention in patients following bariatric surgery.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The aim of the study is to investigate the mechanisms that regulate weight loss, particularly following bariatric surgery. Previous animal studies have suggested that there is an underlying regulatory process controlled by 'the gravitostat' which is an evolutionary adaptation responsible for weight control and maintenance. Studies exploring this concept in rodent models have suggested that artificially increasing the animal's weight with the implantation of weighted capsules results in greater weight loss in mice with obesity but does not affect those of normal weight. We will use weighted vests in patients following surgery to replicate this increased mechanical loading to determine whether a similar process occurs in humans. This will improve our understanding of the underlying processes regulating weight in patients with obesity and following bariatric surgery.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: External mechanical loading Following bariatric surgery (RYGB or SG) patients will be asked to wear a weighted vest for a minimum of 8 hours daily and during physical exercise for three months postoperatively. Weight will be incrementally added on a weekly basis to maintain the baseline weight as patients lose weight following surgery up to a maximum of 15%. |
Device: Weighted vest
Patients will wear a weighted vest following bariatric surgery with weight increased incrementally to maintain baseline weight. This vest will be worn for a minimum of 8 hours a day for three months postoperatively.
|
| No Intervention: Standard postoperative care Patients following bariatric surgery (RYGB or SG) will receive standard postoperative care. |
Outcome Measures
Primary Outcome Measures
- Fat free mass retention [1 year]
Fat free mass retention as measured using DEXA scan
- Weight loss [1 year]
Weight loss (kg)
Secondary Outcome Measures
- Changes in protein and inflammatory marker levels [1 year]
Change in myostatin, lipocalin-2, IGF-1, IL-6, testosterone
Eligibility Criteria
Criteria
Inclusion Criteria:
- Undergoing bariatric surgery- Roux en Y gastric bypass or sleeve gastrectomy Age 18-60 BMI >30kg/m2 Reporting regular physical exercise (>3 days/week) Willingness to comply with the study protocol
Exclusion Criteria:
- Sedentary lifestyle Chronic pain that is constant and impairs the quality of life such as severe back, hip or knee pain Reduced mobility requiring the use of a mobility aid Undergoing revisional surgery Concerns from the investigator that the participant will be unable to fully comply with the study protocol
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University College Dublin
Investigators
- Principal Investigator: Carel W le Roux, PhD, University College Dublin
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RS20-012